Cobalt Blue Holdings Ltd (ASX: COB) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cobalt Blue Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cobalt Blue Holdings Ltd (ASX: COB)
Latest News
Share Market News
Why is everyone talking about ASX cobalt shares this week?
Materials Shares
This ASX mining share rocketed 21% today. Here's why
Materials Shares
Here's why the Cobalt Blue (ASX:COB) share price is surging 11% today
Share Market News
Victoria to tax electric vehicles? What this could mean for ASX lithium shares
Share Market News
Why the Cobalt Blue (ASX:COB) share price is rocketing 6% today
Share Market News
The Cobalt Blue (ASX:COB) share price is rocketing 13% today. Here's why
COB ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Cobalt Blue Holdings Ltd
Cobalt Blue Holdings Ltd focuses upon the development and commercialisation of the Broken Hill Cobalt Deposit, Broken Hill, NSW. Its currently organised into two operating segmentsBroken Hill Cobalt Project and Kwinana Cobalt Refinery Project.
COB Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
23 Dec 2024 | $0.07 | $0.00 | 0.00% | 361,048 | $0.07 | $0.07 | $0.07 |
20 Dec 2024 | $0.07 | $0.00 | 0.00% | 247,162 | $0.07 | $0.07 | $0.07 |
19 Dec 2024 | $0.07 | $0.00 | 0.00% | 484,890 | $0.07 | $0.07 | $0.07 |
18 Dec 2024 | $0.07 | $0.00 | 0.00% | 287,726 | $0.07 | $0.07 | $0.07 |
17 Dec 2024 | $0.07 | $0.00 | 0.00% | 501,116 | $0.07 | $0.07 | $0.07 |
16 Dec 2024 | $0.07 | $0.00 | 0.00% | 88,360 | $0.07 | $0.07 | $0.07 |
13 Dec 2024 | $0.07 | $0.00 | 0.00% | 129,277 | $0.07 | $0.07 | $0.07 |
12 Dec 2024 | $0.07 | $0.00 | 0.00% | 268,218 | $0.07 | $0.07 | $0.07 |
11 Dec 2024 | $0.07 | $0.00 | 0.00% | 41,370 | $0.07 | $0.07 | $0.07 |
10 Dec 2024 | $0.07 | $0.00 | 0.00% | 471,712 | $0.07 | $0.07 | $0.07 |
09 Dec 2024 | $0.07 | $0.00 | 0.00% | 4,569,006 | $0.07 | $0.08 | $0.07 |
06 Dec 2024 | $0.07 | $0.00 | 0.00% | 543,479 | $0.07 | $0.07 | $0.07 |
05 Dec 2024 | $0.07 | $0.00 | 0.00% | 566,650 | $0.07 | $0.07 | $0.07 |
04 Dec 2024 | $0.07 | $0.00 | 0.00% | 835,324 | $0.07 | $0.07 | $0.07 |
03 Dec 2024 | $0.07 | $0.00 | 0.00% | 191,615 | $0.07 | $0.07 | $0.07 |
02 Dec 2024 | $0.07 | $0.00 | 0.00% | 564,104 | $0.07 | $0.07 | $0.07 |
29 Nov 2024 | $0.07 | $0.00 | 0.00% | 235,078 | $0.07 | $0.07 | $0.07 |
28 Nov 2024 | $0.07 | $0.00 | 0.00% | 133,012 | $0.07 | $0.07 | $0.07 |
27 Nov 2024 | $0.07 | $0.00 | 0.00% | 1,238,255 | $0.07 | $0.07 | $0.07 |
26 Nov 2024 | $0.07 | $0.00 | 0.00% | 295,848 | $0.07 | $0.07 | $0.07 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
28 Nov 2024 | Robert Biancardi | Expiry | 333,333 | $22,666 |
As advised by the company. 333,333 Performance Rights awarded in 2021 lapsed
|
28 Nov 2024 | Hugh Keller | Expiry | 333,333 | $22,666 |
As advised by the company. 333,333 Performance Rights awarded in 2021 lapsed
|
25 Jul 2024 | Josef Kaderavek | Exercise | 160,984 | $12,717 |
Conversion of securities. 1,686,995 Rights
|
25 Jul 2024 | Josef Kaderavek | Issued | 160,984 | $12,717 |
Conversion of securities.
|
25 Jul 2024 | Josef Kaderavek | Expiry | 482,955 | $38,153 |
As advised by the company. excluded from partial vesting, 1,204,040 Rights
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Robert Biancardi | Non-Executive ChairmanNon-Executive Director | Sep 2016 |
Mr Biancardi has more than 35 years of commercial experience across the finance, IT, healthcare and services sectors. Mr Biancardi has previously held senior roles at IBM, Citibank and Westpac. His recent roles include director of Evolution Healthcare, a private hospital operator. He has been a director and chief executive officer of several companies, including Rockridge Group (Private Equity) and Hutchisons (Child Care Services) Limited, previously an ASX listed services company. He has served as a director and president of the Restaurant & Catering Association of NSW for 13 years and has been a board member of the Heart Foundation of Australia (FIPOC) for over 7 years. He has corporate advisory and capital management experience with a specialisation in corporate marketing and substantial public/private board experience. He is also member of Risk Committee.
|
Mr Hugh Keller | Non-Executive Director | Oct 2016 |
Mr Keller had a career as a solicitor in Sydney and became a partner at Dawson Waldron (now Ashurst) in 1976 and remained a partner in its successor firms for 34 years until retirement from full time legal practice in 2010. During his time at the firm, Mr Keller served as joint national managing partner, Sydney office managing partner, chairman of the staff superannuation fund, one of the practice leaders and as a board member. He has legal experience and expertise in the review of commercial contracts and arrangements, as well as experience in public company audit committee procedures and requirements and hands on experience in the dynamics of managing people and resources in long term projects. He is Chair of Risk Committee.
|
Mr Josef Kaderavek | Chief Executive OfficerExecutive Director | Oct 2016 |
Mr Kaderavek commenced his career as an RAAF Engineering Officer before transitioning to PricewaterhouseCoopers, where he was responsible for preparing operational reviews and examining strategic options for mining, processing, railway, and port facilities throughout Australia, North America, and Europe. Over the last 15 years he has been involved in equities/investment research (including senior roles with Deutsche Bank and Five Oceans Asset Management) focused on mining, minerals processing and energy storage technologies. Most recently, he held an international consulting role with a focus on renewable energy and battery storage technologies.
|
Mr Grahame Clegg | Company Secretary | Jan 2021 |
-
|
Mr Stewart Morgan | Chief Financial OfficerCompany Secretary | Jan 2021 |
-
|
Stewart Morgan | Chief Financial OfficerCompany Secretary |
-
|
|
Grahame Clegg | Company Secretary |
-
|
|
Andrew Tong | Executive Manager |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Citicorp Nominees Pty Limited | 24,576,664 | 5.82% |
HSBC Custody Nominees (Australia) Limited | 11,194,671 | 2.65% |
A10 Investments Pty Ltd <Dl Family A/C> | 8,380,000 | 1.98% |
Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 7,499,942 | 1.78% |
St Ives No5 Pty Ltd <St Ives No5 A/C> | 7,041,754 | 1.67% |
Mr Josef Thomas Kaderavek and Mrs Ariane Louise Kaderavek <Kaderavek Family A/C> | 6,035,957 | 1.43% |
Mrs Katie Elizabeth Reece | 4,969,565 | 1.18% |
American Rare Earths Limited | 4,396,001 | 1.04% |
Zacob Pty Ltd <R&L Biancardi Super Fund A/C> | 4,120,538 | 0.98% |
Ubs Nominees Pty Ltd | 4,014,252 | 0.95% |
BNP Paribas Nominees Pty Ltd <Clearstream> | 3,868,060 | 0.92% |
Minerals And Residues Pty Ltd <Andrew & Lisa Tong Fam A/C> | 3,824,824 | 0.91% |
Mr Robert Thomas Virgona | 3,662,383 | 0.87% |
Emnara Pty Ltd <Danny Morgan Family A/C> | 3,306,536 | 0.78% |
Mr Paul Stuart Nichols and Ms Therese Mary Nichols <Nichols Super Fund A/C> | 2,835,000 | 0.67% |
Hill Family Group Pty Ltd | 2,734,783 | 0.65% |
Aligned Capital Partnership Pty Ltd <Aligned C Partnership A/C> | 2,714,561 | 0.62% |
Mr Josef Thomas Kaderavek and Mrs Ariane Louise Kaderavek <Kaderavek Superfund A/C> | 2,646,206 | 0.63% |
BNP Paribas Noms Pty Ltd | 2,633,636 | 0.62% |
Coonan Family Superannuation Fund Pty Ltd <Coonan Family S/F A/C> | 2,500,000 | 0.59% |